← Back to Search

Brachytherapy

Ultrasound-Guided Prostate Brachytherapy for Prostate Cancer

N/A
Recruiting
Research Sponsored by Western University, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Suitable for and consenting to high-dose-rate brachytherapy for treatment as standard of care
Male, aged 18 years or older
Must not have
Previous radiotherapy to the prostate
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month following data collection
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new ultrasound method to help guide prostate cancer surgery.

Who is the study for?
This trial is for men aged 18 or older who have been diagnosed with prostate cancer and are suitable and consenting to high-dose-rate brachytherapy as standard care. Participants must be willing to provide written consent. Men who have had previous radiotherapy to the prostate cannot participate.
What is being tested?
The study tests a new method of visualizing the placement of brachytherapy needles in the prostate using power Doppler ultrasound, which may enhance needle localization by making vibrations visible when an oscillator contacts the needle during treatment.
What are the potential side effects?
Since this trial focuses on improving visualization techniques during standard brachytherapy without introducing new drugs, side effects are likely similar to those of regular brachytherapy, such as discomfort at the needle insertion site.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I agree to undergo high-dose-rate brachytherapy as part of my treatment.
Select...
I am a man aged 18 or older.
Select...
My prostate cancer was confirmed through a biopsy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had radiation therapy to my prostate before.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month following data collection
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month following data collection for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Needle Trajectory

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: PatientExperimental Treatment1 Intervention
Patient undergoing standard care prostate high dose rate brachytherapy.

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor
253 Previous Clinical Trials
58,552 Total Patients Enrolled
1 Trials studying Prostate Cancer
45 Patients Enrolled for Prostate Cancer

Media Library

Prostate Brachytherapy (Brachytherapy) Clinical Trial Eligibility Overview. Trial Name: NCT03861507 — N/A
Prostate Cancer Research Study Groups: Patient
Prostate Cancer Clinical Trial 2023: Prostate Brachytherapy Highlights & Side Effects. Trial Name: NCT03861507 — N/A
Prostate Brachytherapy (Brachytherapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03861507 — N/A
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top